ScleroSafe (varicose veins treatment device)

2023: Product Announcement

On September 4, 2023, the Israeli company VVT Medical announced the release of the medical platform ScleroSafe, designed to treat varicose superficial veins of the lower extremities.

Varicose veins are a widespread ailment associated with impaired venous valve function and the occurrence of reverse current (reflux) of blood. In the initial stages of the disease, few and very nonspecific symptoms appear. As the disease develops, there is heaviness in the legs and rapid fatigue of the limbs, aching pain, swelling of the legs, thickening of the veins, burning and itching. The ScleroSafe system enables minimally invasive treatment of varicose veins.

VVT Medical ScleroSafe

The technology is based on the use of endovenous chemical ablation. The platform includes a combined dual syringe of reverse action and a catheter. During therapy, a special substance is injected into a vein through one syringe, and blood is simultaneously absorbed through the second. The whole procedure is carried out with one hand, and pain is minimal. In addition, the proposed treatment method does not leave scarring and other visible changes on the skin.

The Food and Drug Administration (FDA) has approved the use of the ScleroSafe system in the United States. In addition, VVT Medical has obtained permits to distribute the product in many regions around the world, including Europe, Australia, Southeast Asia and South America.

ScleroSafe promises to change the treatment of varicose veins by giving patients a safe, effective and easy option. We firmly believe that our decision can make positive changes in the lives of a huge number of people on a global scale, says the Israeli company.[1]

Notes